D-0331-2021 Class III Terminated
FDA drug recall D-0331-2021 was initiated by Teligent Pharma, Inc. on Mar 29, 2021 and is designated Class III. Reason for recall: Failed Stability Specifications: product did not meet viscosity results. The recall status is terminated (terminated Jul 3, 2024). Affected quantity: 62,040 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 21, 2021
- Initiation Date
- Mar 29, 2021
- Termination Date
- Jul 3, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 62,040 tubes
Product description
Lidocaine Ointment USP, 5%, NET WT 35.44 g (1 1/4 Oz) tube, Rx Only, Teligent Pharma Inc., Buena, New Jersey, 08310, NDC 52565-008-14.
Reason for recall
Failed Stability Specifications: product did not meet viscosity results.
Distribution pattern
Nationwide in the USA
Code information
Lot 13269, Exp March 2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0331-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026